Verici Dx Revenue

Verici Dx had revenue of $1.91M USD in the half year ending June 30, 2025, with 9,968.42% growth. This brings the company's revenue in the last twelve months to $1.91M, down -55.85% year-over-year. In the year 2024, Verici Dx had annual revenue of $3.34M with 229.62% growth.

Revenue (ttm)

$1.91M

Revenue Growth

-55.85%

P/S Ratio

9.21

Revenue / Employee

$106.28K

Employees

Market Cap

12.86M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.34M	2.33M	229.62%
Dec 31, 2023	1.01M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	43.24B
GSK plc	32.17B
Haleon	11.02B
Smith & Nephew	4.33B
Convatec Group	1.72B
Hikma Pharmaceuticals	2.35B
HUTCHMED (China)	439.54M
Genus	672.80M

Revenue Rankings

Verici Dx News

2 months ago - Verici Dx Plc (VRCDF) Interim Results Investor Presentation Call Transcript - Seeking Alpha
2 months ago - Verici Dx plc - Special Call - Seeking Alpha
7 months ago - AIM Market Roundup: Belluscura, Tiger Royalties, ITM Power - The Armchair Trader
8 months ago - AIM Market Roundup: Ethernity Networks, Verici DX, Aferian - The Armchair Trader
8 months ago - AIM Market Roundup: Rome Resources, Celadon Pharmaceuticals, Churchill China - The Armchair Trader
8 months ago - AIM Market Roundup: Celadon Pharma, Oracle Power, Volex - The Armchair Trader
1 year ago - FBB Biomed Signs Agreement with Verici Dx plc to Offer Research-Use-Only “RUO” Tests to Clinicians - Business Wire

More News